Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,631,235
+$8,857,233 QoQ
Shares Held
1,411,477
+0.9% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 304 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Derivatives in SRRK
reported options exposure · as of Mar 31, 2026CallValue
$624,332
CallShares
12,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. SRRK ranks #45 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in SRRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,631,235 | 1,411,477 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $68,774,002 | 1,398,983 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $624,332 | 12,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $58,331,582 | 1,324,213 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $58,209,433 | 1,563,089 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $45,690,842 | 1,289,973 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $45,152,199 | 1,404,423 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $74,363,553 | 1,720,582 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $11,207,607 | 1,399,202 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,154,544 | 1,339,081 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,882,912 | 1,232,146 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $26,898,362 | 1,430,764 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $7,725,324 | 1,088,074 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,486,669 | 1,390,805 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $8,357,896 | 1,044,737 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,466,930 | 272,589 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,934,417 | 423,437 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $909,747 | 165,710 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,937,637 | 150,321 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,115,513 | 44,908 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,105,575 | 33,482 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,521,195 | 260,249 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,929,546 | 255,222 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,287,664 | 67,745 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $348,829 | 19,719 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $827,006 | 45,415 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $290,434 | 23,983 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||